1 / 16

Infective Endocarditis (IE)

Infective Endocarditis (IE). A microbial infection of a cardiac valve or the endocardium caused by bacteria, fungi, or chlamydia Often categorized as acute or subacute based on the rapidity of the clinical course

dacian
Download Presentation

Infective Endocarditis (IE)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Infective Endocarditis (IE) • A microbial infection of a cardiac valve or the endocardiumcaused by bacteria, fungi, or chlamydia • Often categorized as acute or subacute based on the rapidity of the clinical course • Alternatively described by type of risk factor e.g., nosocomial,prostheticvalve, intravenous drug use - associated • Pathological findings include the presence of friable valvularvegetations containing bacteria, fibrin and inflammatory cells. There is often valvulardestruction with extension to adjacent structures.

  2. Epidemiology • 3.6 to 7.0 cases per 100,000 patient-years • ~1 in 1280 pediatric admissions per year • age of subjects with endocarditis has increased over the past 60 years (30-40 to 47-69) • Among injecting drug users the incidence is as high as 150 - 2000/100,000 person years

  3. Microbiology of Native Valve Endocarditis Karchmer, Scientific American Medicine, 1999

  4. Risk Factors • Intravenous drug abuse • Intravascular prostheses • Nosocomial exposure • Hemodialysis • Valvular Heart Disease • age-related valvular sclerosis • rheumatic heart disease • Congenital heart disease

  5. Risk Factors • Dental procedures, poor dental hygiene • viridans streptococci, nutritionally variant streptococci, HACEK • Prosthetic valves • Early: coagulase negative staphylococci, S. aureus • Late: coagulase negative staphylococci, viridans streptococci • Gastrointestinal or genitourinary procedures • enterococcior S. bovis (colon carcinoma) • Nosocomial • S. aureus (including MRSA), Gram negatives, Candida species

  6. Pathogenesis

  7. Factors Contributing to the Pathogenesis of Endocarditis • Hemodynamics - blood flow patterns • Bacterial properties • Host factors

  8. Pathogenesis *Endothelial damage caused by turbulent blood flow seen in congenital or acquired heart disease

  9. Pathogenesis • Inoculation of bacteria colonizing a mucosal (e.g., oral mucosa) or peripheral tissue site into the bloodstream • Transient bacteremia of a serum-resistant pathogen capable of adhering to a cardiac valvular surface • Turbulent blood flow across the valve • Bacterial adherence to cardiac valvular surface • Pathogen - host tissue interaction resulting in vegetation formation and local tissue damage • Bacterial persistence • Dissemination of infection to other tissue sites and elicitation of systemic findings

  10. Host Factors Involved in thePathogenesis of Infective Endocarditis • Valvular surfaces • Nonbacterial thrombus forms on damaged valves • Direct adherence to the endovascular surface of normal valves • Suture line, valve surface of prosthetic valves • Platelets dual role • Platelet microbicidal proteins (α-granules) • Bacteria induce platelet aggregation • Part of nonbacterial thrombus surface • Leukocytes, complement, cytokines

  11. Bacterial Factors Involved in thePathogenesis of Infective Endocarditis • Serum resistance - i.e. complement • Bacterial adhesins mediate binding to the nonbacterial thrombus and to endothelial cells: dextran, fibrinogen-binding proteins • Invasive potential of bacteria • Ability to elaborate extracellular proteases • Capacity for metastatic seeding • Stimulation of tissue factor activity

  12. Classification • Subacute IE • develops insidiously and progresses slowly (over weeks to months) • caused most commonly by streptococci (especially viridans, microaerophilic, anaerobic, and nonenterococcal group D streptococci and enterococci) • Acute IE • develops abruptly and progresses rapidly (over days) • usually caused by S. aureus, group A hemolytic streptococci, pneumococci, or gonococci

  13. Clinical Findings • Secondary to 4 underlying phenomena • bacteremia (or fungemia) • Fever, fatigue,weakness, arthralgias, myalgias, weight loss, rigors, and diaphoresis (non-specific findings) • Valvulitis • changing cardiac auscultatory findings • development ofcongestive heart failure • Extracardiac manifestations • petechiae, hemorrhages, Roth’s spots, or splenomegaly • immunologic responses • Renal abnormalities (eg, glomerulonephritis,infarct) • Osler nodes • Emboli • Emboli to the abdominal viscera, the brain, or theheart may produce symptoms associated with ischemia and/or hemorrhage • Janeway lesions

  14. Roth spots • retinal hemorrhages with pale or yellow center • Osler's nodes • painful, palpable, erythematous lesions most often involving the pads of the fingers and toes • local inflammation associated with an immunologic reaction • Janeway lesions • nontender, macular lesions most commonly involving the palms and soles • caused by septic emboli

  15. Cutaneous Manifestations of Endocarditis Splinter Hemorrhages A – C. Osler Nodes: D. Janeway lesion

More Related